Significance of Elevated Levels of Collagen Type IV and Hyaluronic Acid in Gastric Juice and Serum in Gastric Cancer and Precancerous Lesion

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2011 Jan 26

PMID 21264511

Citations 4

Authors

Hai-Ling Ruan

Ru-Tao Hong

Hui-Jun Xie

Nai-Zhong Hu

Jian-Ming Xu

Wei Zhang

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Collagen type IV and hyaluronic acid (HA) are the major components of basement membrane and extracellular matrix, respectively. Cathepsin D is an aspartyl lysosomal protease involved in the degradation of the basement membrane and extracellular matrix. The aim of this study is to investigate the clinical significance of collagen type IV and hyaluronic acid in gastric juice and serum in diagnosis of gastric cancer and the degrading effect of cathepsin D on collagen type IV and HA.

Methods: Fifty gastric cancer patients were enrolled in our study compared with 41 patients with precancerous lesion and 30 control subjects. Collagen type IV and HA in gastric juice and serum were analyzed by radioimmunoassay. Expression of cathepsin D and collagen type IV in tissue were analyzed by immunohistochemical staining with monoclonal antibodies.

Results: The contents of collagen type IV and HA in gastric juice and HA in serum were significantly higher in patients with gastric cancer than those in patients with precancerous lesion and control group (p < 0.05, p < 0.0001). Gastric cancer patients with lymph node metastasis had a higher level of collagen type IV and HA in gastric juice than those in patients without metastasis (p = 0.049, p = 0.043). The expression of cathepsin D had significantly increased in patients with gastric cancer compared to the control group (p < 0.0001). The continuous expression of collagen type IV in basement membrane in gastric cancer group was lower than that in the precancerous lesion group and control group (p < 0.0001).

Conclusions: The analysis of collagen type IV and HA in gastric juice and serum may provide a simple aid in diagnosing gastric cancer and evaluating whether metastasis is occurring or not.

Citing Articles

Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis.

Xu Y, Benedikt J, Ye L Cancers (Basel). 2024; 16(10).

PMID: 38791985 PMC: 11119954. DOI: 10.3390/cancers16101907.

Gastric cancer detection by non-blood-based liquid biopsies: A systematic review looking into the last decade of research.

Lopes C, Chaves J, Ortigao R, Dinis-Ribeiro M, Pereira C United European Gastroenterol J. 2022; 11(1):114-130.

PMID: 36461757 PMC: 9892482. DOI: 10.1002/ueg2.12328.

Detection of digestive malignancies and post-gastrectomy complications via gastrointestinal fluid examination.

Huang L, Xu A Front Med. 2017; 11(1):20-31.

PMID: 28213880 DOI: 10.1007/s11684-016-0493-4.

Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.

Pinheiro D, Ferreira W, Leao Barros M, Araujo M, Rodrigues-Antunes S, Borges B World J Gastroenterol. 2014; 20(33):11574-85.

PMID: 25206265 PMC: 4155351. DOI: 10.3748/wjg.v20.i33.11574.

References

Yeh J, Hur C, M Kuntz K, Ezzati M, Goldie S . Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer. Cancer. 2010; 116(12):2941-53. PMC: 2946062. DOI: 10.1002/cncr.25030. View

Setala L, Tammi M, Tammi R, Eskelinen M, Lipponen P, Agren U . Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer. 1999; 79(7-8):1133-8. PMC: 2362238. DOI: 10.1038/sj.bjc.6690180. View

Gomez C, Gomez P, Knapp J, Jorda M, Soloway M, Lokeshwar V . Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence. J Urol. 2009; 182(4):1350-6. PMC: 2828051. DOI: 10.1016/j.juro.2009.06.070. View

Ikeguchi M, Fukuda K, Oka S, Hisamitsu K, Katano K, Tsujitani S . Micro-lymph node metastasis and its correlation with cathepsin D expression in early gastric cancer. J Surg Oncol. 2001; 77(3):188-94. DOI: 10.1002/jso.1093. View

Abbott D, Margaryan N, Jeruss J, Khan S, Kaklamani V, Winchester D . Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther. 2009; 9(1):23-30. PMC: 3187721. DOI: 10.4161/cbt.9.1.10378. View

Goishi H, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G . Predictive value of cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer. Oncol Rep. 2000; 7(4):713-8. DOI: 10.3892/or.7.4.713. View

Korenaga D, Orita H, Maekawa S, Itasaka H, Ikeda T, Sugimachi K . Peritoneal collagen type IV concentration in adenocarcinoma of the gastrointestinal tract and its relationship to histological differentiation, metastasis, and survival. Surg Today. 1998; 28(8):780-6. DOI: 10.1007/s005950050226. View

Szajda S, Snarska J, Roszkowska-Jakimiec W, Waszkiewicz N, Siedlecka K, Zwierz K . [Activity of cathepsin D in the blood serum and urine of patients with cancer of the stomach, pancreas and liver]. Pol Arch Med Wewn. 2008; 116(6):1150-4. View

Baba Y, Iyama K, Ikeda K, Ishikawa S, Hayashi N, Miyanari N . Differential expression of basement membrane type IV collagen alpha chains in gastric intramucosal neoplastic lesions. J Gastroenterol. 2007; 42(11):874-80. DOI: 10.1007/s00535-007-2112-2. View

10.

Yabushita H, Kishida T, Fusano K, Kanyama K, Zhuo L, Itano N . Role of hyaluronan and hyaluronan synthase in endometrial cancer. Oncol Rep. 2005; 13(6):1101-5. View

11.

Mazouni C, Arun B, Andre F, Ayers M, Krishnamurthy S, Wang B . Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers. Br J Cancer. 2008; 99(1):68-71. PMC: 2453019. DOI: 10.1038/sj.bjc.6604443. View

12.

Zaidi N, Maurer A, Nieke S, Kalbacher H . Cathepsin D: a cellular roadmap. Biochem Biophys Res Commun. 2008; 376(1):5-9. DOI: 10.1016/j.bbrc.2008.08.099. View

13.

Allgayer H, Babic R, Grutzner K, Beyer B, Tarabichi A, Wilhelm Schildberg F . An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis. Cancer. 1997; 80(2):179-87. DOI: 10.1002/(sici)1097-0142(19970715)80:2<179::aid-cncr2>3.0.co;2-p. View

14.

Paiva P, Van Damme M, Tellbach M, Jones R, Jobling T, Salamonsen L . Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol. 2005; 98(2):193-202. DOI: 10.1016/j.ygyno.2005.02.031. View

15.

Ohlund D, Lundin C, Ardnor B, Oman M, Naredi P, Sund M . Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. Br J Cancer. 2009; 101(1):91-7. PMC: 2713699. DOI: 10.1038/sj.bjc.6605107. View

16.

Leto G, Tumminello F, Crescimanno M, Flandina C, Gebbia N . Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis. 2004; 21(2):91-106. DOI: 10.1023/b:clin.0000024740.44602.b7. View

17.

Charalabopoulos K, Mittari E, Karakosta A, Golias C, Batistatou A . Integrins adhesion molecules and some of their ligands in laryngeal cancer. Exp Oncol. 2005; 27(2):86-90. View

18.

Dragutinovic V, Izrael-Zivkovic L, Radovanovic N . Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer. Dig Dis Sci. 2008; 54(6):1203-7. DOI: 10.1007/s10620-008-0472-y. View

19.

Ikeguchi M, Fukuda K, Oka S, Yamaguchi K, Hisamitsu K, Tsujitani S . Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma. Oncology. 2001; 61(1):71-8. DOI: 10.1159/000055356. View

20.

Szumilo J, Burdan F, Zinkiewicz K, Dudka J, Klepacz R, Dabrowski A . Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma. Folia Histochem Cytobiol. 2010; 47(4):571-8. DOI: 10.2478/v10042-008-0012-8. View